1
|
Takeshita T, Nukada Y, Nakagawa S, Terasaka S, Miyazawa M. Development of internal thresholds of toxicological concern (iTTC) for chemicals based on empirical exposures to pharmaceuticals. Regul Toxicol Pharmacol 2025; 160:105832. [PMID: 40246139 DOI: 10.1016/j.yrtph.2025.105832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2024] [Revised: 04/08/2025] [Accepted: 04/15/2025] [Indexed: 04/19/2025]
Abstract
The threshold of toxicological concern (TTC) is an approach to risk assessment that uses acceptable low-level exposure values derived from statistical information for chemicals for which insufficient toxicological information exists. Previously, the TTC for systemic toxicity was derived from the toxicological endpoints of the external dose for each administration route in animal studies. Internal TTC (iTTC), which extends the TTC concept from external to internal dosages, expands the scope of application by standardizing exposure via different routes. Information about blood exposure to pharmaceuticals used in treatment can help determine the chemical levels tolerated in humans. Using the tolerated plasma/serum blood drug concentration of the pharmaceutical as the toxicological point of departure, a new iTTC of 0.6 nM for the no effect concentration were proposed (a conservative risk assessment considers further safety margins). It is based on the 5th percentile values of the normal distribution, which approximates the cumulative empirical distribution, and an uncertainty coefficient to convert the treatment dose to the no-effect dose. Predicting blood concentrations of chemicals to which humans are exposed and comparing them to iTTC with appropriate caution can be used as an approach to risk assessment of systemic toxicity without animal-based testing.
Collapse
Affiliation(s)
| | - Yuuko Nukada
- R&D, Safety Science Research, Kao Corporation, Tochigi, 321-3497, Japan
| | - Shota Nakagawa
- R&D, Safety Science Research, Kao Corporation, Tochigi, 321-3497, Japan
| | - Shimpei Terasaka
- R&D, Safety Science Research, Kao Corporation, Tochigi, 321-3497, Japan
| | - Masaaki Miyazawa
- R&D, Safety Science Research, Kao Corporation, Tochigi, 321-3497, Japan
| |
Collapse
|
2
|
Chellian R, Behnood-Rod A, Wilson R, Lin K, Wing-Yan King G, Bruijnzeel AW. The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats. J Psychopharmacol 2023; 37:216-228. [PMID: 36680471 DOI: 10.1177/02698811221147141] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
BACKGROUND The reinforcing properties of nicotine play a critical role in smoking and vaping. There is a need for treatments that decrease the reinforcing properties of nicotine and thereby improve smoking and vaping rates. Dopamine plays a role in the reinforcing properties of nicotine, but little is known about the role of dopamine D2-like receptors in nicotine intake and whether there are sex differences in the effects of dopaminergic drugs on nicotine intake. AIM The goal of the present studies was to investigate the effects of the D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 on nicotine self-administration in male and female rats. METHODS The effects of flupentixol and L-741626 on operant responding for nicotine and food and locomotor activity in a small open field were investigated. RESULTS There were no sex differences in baseline nicotine intake. The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decreased operant responding for nicotine. Blockade of D1/D2-like receptors and blockade of D2-like receptors also decreased operant responding for food and decreased locomotor activity. Flupentixol induced a greater decrease in operant responding for food in males than females. However, in the other tests, there were no sex differences in the effects of the dopamine receptor antagonists. CONCLUSIONS Blockade of D1/D2-like receptors with flupentixol and D2-like receptors with L-741626 decreases nicotine and food intake in rats of both sexes. These compounds also decrease locomotor activity which might be indicative of a sedative effect.
Collapse
Affiliation(s)
| | - Azin Behnood-Rod
- Department of Psychiatry, University of Florida, Gainesville, FL, USA
| | - Ryann Wilson
- Department of Psychiatry, University of Florida, Gainesville, FL, USA
| | - Karen Lin
- Department of Psychiatry, University of Florida, Gainesville, FL, USA
| | | | | |
Collapse
|
3
|
Opendak M, Raineki C, Perry RE, Rincón-Cortés M, Song SC, Zanca RM, Wood E, Packard K, Hu S, Woo J, Martinez K, Vinod KY, Brown RW, Deehan GA, Froemke RC, Serrano PA, Wilson DA, Sullivan RM. Bidirectional control of infant rat social behavior via dopaminergic innervation of the basolateral amygdala. Neuron 2021; 109:4018-4035.e7. [PMID: 34706218 PMCID: PMC8988217 DOI: 10.1016/j.neuron.2021.09.041] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Revised: 07/08/2021] [Accepted: 09/21/2021] [Indexed: 10/20/2022]
Abstract
Social interaction deficits seen in psychiatric disorders emerge in early-life and are most closely linked to aberrant neural circuit function. Due to technical limitations, we have limited understanding of how typical versus pathological social behavior circuits develop. Using a suite of invasive procedures in awake, behaving infant rats, including optogenetics, microdialysis, and microinfusions, we dissected the circuits controlling the gradual increase in social behavior deficits following two complementary procedures-naturalistic harsh maternal care and repeated shock alone or with an anesthetized mother. Whether the mother was the source of the adversity (naturalistic Scarcity-Adversity) or merely present during the adversity (repeated shock with mom), both conditions elevated basolateral amygdala (BLA) dopamine, which was necessary and sufficient in initiating social behavior pathology. This did not occur when pups experienced adversity alone. These data highlight the unique impact of social adversity as causal in producing mesolimbic dopamine circuit dysfunction and aberrant social behavior.
Collapse
Affiliation(s)
- Maya Opendak
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Kennedy Krieger Institute, Baltimore, MD 21205, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
| | - Charlis Raineki
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Psychology, Brock University, St. Catharines, ON L2S 3A1, Canada
| | - Rosemarie E Perry
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Applied Psychology, New York University, New York, NY 10012, USA
| | - Millie Rincón-Cortés
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Neuroscience, University of Pittsburgh, Pittsburgh PA 15260, USA
| | - Soomin C Song
- Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA; Neuroscience Institute, New York University School of Medicine, New York, NY 10016, USA
| | - Roseanna M Zanca
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Psychology, CUNY Hunter College, New York, 10016, USA; The Graduate Center of CUNY, New York, 10016, USA
| | - Emma Wood
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
| | - Katherine Packard
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
| | - Shannon Hu
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
| | - Joyce Woo
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
| | - Krissian Martinez
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA
| | - K Yaragudri Vinod
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Analytical Psychopharmacology, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
| | - Russell W Brown
- Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA
| | - Gerald A Deehan
- Department of Psychology, East Tennessee State University, Johnson City, TN 37614, USA
| | - Robert C Froemke
- Center for Neural Science, New York University, New York, NY 10003, USA; Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA; Neuroscience Institute, New York University School of Medicine, New York, NY 10016, USA; Department of Otolaryngology, New York University School of Medicine, New York, NY 10016, USA; Department of Neuroscience and Physiology, New York University School of Medicine, New York, NY 10016, USA
| | - Peter A Serrano
- Department of Psychology, CUNY Hunter College, New York, 10016, USA; The Graduate Center of CUNY, New York, 10016, USA
| | - Donald A Wilson
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Center for Neural Science, New York University, New York, NY 10003, USA
| | - Regina M Sullivan
- Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY 10016, USA; Emotional Brain Institute, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Center for Neural Science, New York University, New York, NY 10003, USA.
| |
Collapse
|
4
|
Oztas B, Sahin D, Kir H, Eraldemir FC, Musul M, Kuskay S, Ates N. The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-Α, Il-1β, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model. Neuropeptides 2017; 61:31-37. [PMID: 27522536 DOI: 10.1016/j.npep.2016.08.002] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 08/04/2016] [Indexed: 12/26/2022]
Abstract
The objective of this study is to examine the effects of the endogenous ligands leptin, ghrelin, and neuropeptide Y (NPY) on seizure generation, the oxidant/antioxidant balance, and cytokine levels, which are a result of immune response in a convulsive seizure model. With this goal, Wistar rats were divided into 5 groups-Group 1: Saline, Group 2: Saline+PTZ (65mg/kg), Group 3: leptin (4mg/kg)+PTZ, Group 4: ghrelin (80μg/kg)+PTZ, and Group 5: NPY (60μg/kg)+PTZ. All injections were delivered intraperitoneally, and simultaneous electroencephalography (EEG) records were obtained. Seizure activity was scored by observing seizure behavior, and the onset time, latency, and seizure duration were determined according to the EEG records. At the end of the experiments, blood samples were obtained in all groups to assess the serum TNF-α, IL-1β, IL-6, FGF-2, galanin, nitric oxide (NOֹ), malondialdehyde (MDA), and glutathione (GSH) levels. The electrophysiological and biochemical findings (p<0.05) of this study show that all three peptides have anticonvulsant effects in the pentylenetetrazol (PTZ)-induced generalized tonic-clonic convulsive seizure model. The reduction of the levels of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 caused by leptin, ghrelin, and NPY shows that these peptides may have anti-inflammatory effects in epileptic seizures. Also, leptin significantly increases the serum levels of the endogenous anticonvulsive agent galanin. The fact that each one of these endogenous peptides reduces the levels of MDA and increases the serum levels of GSH leads to the belief that they may have protective effects against oxidative damage that is thought to play a role in the pathogenesis of epilepsy. Our study contributes to the clarification of the role of these peptides in the brain in seizure-induced oxidative stress and immune system physiology and also presents new approaches to the etiology and treatment of tendency to epileptic seizures.
Collapse
Affiliation(s)
- Berrin Oztas
- Sisli Hamidiye Etfal Research and Training Hospital, Department of Biochemistry, Istanbul, Turkey
| | - Deniz Sahin
- Kocaeli University, Faculty of Medicine, Department of Physiology, Kocaeli, Turkey.
| | - Hale Kir
- Kocaeli University, Faculty of Medicine, Department of Biochemistry, Kocaeli, Turkey
| | - Fatma Ceyla Eraldemir
- Kocaeli University, Faculty of Medicine, Department of Biochemistry, Kocaeli, Turkey
| | - Mert Musul
- Carsamba State Hospital, Department of Biochemistry, Samsun, Turkey
| | - Sevinç Kuskay
- Kocaeli University, Faculty of Medicine, Department of Biochemistry, Kocaeli, Turkey
| | - Nurbay Ates
- Kocaeli University, Faculty of Medicine, Department of Physiology, Kocaeli, Turkey
| |
Collapse
|